Levopidon (Levomethadone Hydrochloride)

Levopidon (levomethadone hydrochloride) acts on opioid receptors and is used in the following clinical situations:

• Opioid dependence treatment: Helps stabilize patients undergoing opioid substitution therapy and reduces withdrawal symptoms.
• Chronic pain management: Provides analgesia for severe, long‑term pain when other opioids are insufficient.
• Opioid withdrawal mitigation: Assists in tapering patients off stronger opioids by offering a controlled agonist effect.

• Levomethadone hydrochloride is a potent μ‑opioid receptor agonist that activates the receptor to produce analgesia and suppress withdrawal. Simultaneously it acts as an N‑methyl‑D‑aspartate (NMDA) receptor antagonist, which may reduce opioid tolerance and hyperalgesia. By binding preferentially to the μ‑receptor with reduced affinity for κ‑receptors, it offers a smoother pharmacologic profile compared with racemic methadone. The combined μ‑agonism and NMDA antagonism contributes to both analgesic efficacy and mitigation of dependence-related neuroadaptations.

Levomethadone may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Drowsiness: increased sleepiness or fatigue.
• Constipation: reduced bowel movements.
• Dry mouth: decreased salivation.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing, potentially life‑threatening.
• Cardiac arrhythmia: irregular heart rhythm, including QT prolongation.
• Severe hypotension: marked drop in blood pressure.
• Allergic reaction: rash, itching, swelling, or anaphylaxis.

When prescribing Levopidon, several safety considerations should be observed:

• Dose titration: adjust gradually under medical supervision to minimize withdrawal or overdose.
• Concurrent CNS depressants: avoid or monitor use with benzodiazepines, alcohol, or other opioids.
• Renal or hepatic impairment: use with caution and consider dose reduction.
• Pregnancy and lactation: assess risk–benefit before prescribing.
• Patient monitoring: regularly evaluate respiratory function, sedation level, and signs of dependence.
• Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Levomethadone can interact with other medicines, requiring careful management.

Major Interactions (Avoid)

• Other opioids: additive respiratory depression risk.
• Benzodiazepines or sedatives: increased CNS depression.
• CYP3A4 inhibitors (e.g., ketoconazole): may raise levomethadone plasma levels.

Moderate Interactions (Monitor Closely)

• CYP3A4 inducers (e.g., rifampin): may reduce efficacy.
• Serotonergic agents (e.g., SSRIs): risk of serotonin syndrome.
• QT‑prolonging drugs (e.g., macrolide antibiotics): potential cardiac arrhythmia.